Screener
Neurocrine Biosciences NBIX Common Stock Shares Issued
Common Stock Shares Issued at other companies
Other financials
Where this comes from
Reported directly by Neurocrine Biosciences in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The source filing: Neurocrine Biosciences’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:02 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000914475-26-000026
| (in millions, except per share data) | March 31,2026 | December 31,2025 |
|---|---|---|
| Total liabilities | 1,498.8 | 1,378.4 |
| Stockholders’ equity: | ||
| Preferred stock, $0.001 par value; 5.0 shares authorized; no shares issued and outstanding | — | — |
| Common stock, $0.001 par value; 220.0 shares authorized; 100.6 and 100.1 shares issued and outstanding, respectively | 0.1 | 0.1 |
| Additional paid-in capital | 2,817.3 | 2,792.2 |
| Accumulated other comprehensive income | 0.4 | 13.1 |
| Retained earnings | 589.6 | 447.7 |
| Total stockholders’ equity | 3,407.4 | 3,253.1 |
Item 1. Financial Statements
FAQ
- What is Neurocrine Biosciences's common stock shares issued?
- Neurocrine Biosciences (NBIX) reported common stock shares issued of 100.6M in Q1 2026.
- How has Neurocrine Biosciences's common stock shares issued changed year-over-year?
- Neurocrine Biosciences's common stock shares issued increased by 1.6% year-over-year, from 99M to 100.6M.
- What is the long-term trend for Neurocrine Biosciences's common stock shares issued?
- Over 5 years (2020 to 2025), Neurocrine Biosciences's common stock shares issued has grown at a 1.4% compound annual growth rate (CAGR), from 93.5M to 100.1M.
- What does common stock shares issued mean?
- The total number of shares that have been authorized and distributed by the corporation since its inception. This includes shares held by the public (outstanding) as well as any shares that the company has repurchased and holds in its treasury. It represents the historical volume of equity capital creation.
Ask your AI about Neurocrine Biosciences's common stock shares issued.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude